TipHub

₹807

▲ +10.44 +1.31%

As of 06 Nov 2026 · delayed

NSE Listed

Natco Pharma Ltd. (NATCOPHARM)

Volume: 7,12,913Avg Vol 1W: 4,38,002.4Avg Vol 1M: 4,60,500.752W Range:₹773.6₹1,226.8
NSE BSE www.natcopharma.co.in AI Report
Key Ratios
Checked 8h ago
Market Cap₹15,831 Cr
Current Price₹807
Previous Close₹796.56
High / Low (52w)₹1,226.8 / ₹773.6
Volume7,12,913
Avg Vol (1W)4,38,002.4
Avg Vol (1M)4,60,500.7
Stock P/E13.84
Book Value₹535.28
Dividend Yield57%
ROE15.38%
ROA9.16%
Revenue (TTM)₹4,376 Cr
Revenue Growth10.8%
Profit Margin32.84%
Total Debt₹0 Cr
Shares Outstanding20 Cr
Face Value₹2
EPS (TTM)₹58.33
P/B1.51
Debt / Equity0.06
50 DMA₹813.74
200 DMA₹929.57
Day change+1.31%
Price Chart
₹807▲ 0.81% · 1Y
₹1206₹7822.3Cr
2025-11-06
2026-11-06

20-day avg volume: 4.6L shares

Pros
  • Healthy return on equity of 15.4%.
  • Pays a dividend yield of 57.0%.
  • Company is almost debt-free.
  • Revenue grew 10% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹1,371 Cr₹475 Cr₹1,221 Cr₹1,329 Cr₹1,363 Cr₹647 Cr₹739 Cr₹735 Cr
EBITDA₹822 Cr₹168 Cr₹516 Cr₹575 Cr₹627 Cr₹171 Cr₹155 Cr₹199 Cr
Net Profit₹677 Cr₹133 Cr₹407 Cr₹481 Cr₹518 Cr₹152 Cr₹268 Cr₹207 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹4,784 Cr₹1,157 Cr₹1,193 Cr₹1,264 Cr₹529 Cr₹609 Cr₹4,376 Cr₹597 Cr
EBITDA₹2,315 Cr₹530 Cr₹546 Cr₹598 Cr₹134 Cr₹120 Cr₹1,528 Cr₹112 Cr
Net Profit₹1,885 Cr₹428 Cr₹464 Cr₹501 Cr₹107 Cr₹210 Cr₹1,419 Cr₹75 Cr
EPS105.26—————79.2—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹4,303 Cr₹4,588 Cr₹4,792 Cr₹5,109 Cr₹5,657 Cr₹6,906 Cr₹8,631 Cr₹11,074 Cr
Total Liabilities₹812 Cr₹803 Cr₹669 Cr₹846 Cr₹784 Cr₹1,053 Cr₹1,019 Cr₹1,853 Cr
Equity₹3,491 Cr₹3,785 Cr₹4,123 Cr₹4,264 Cr₹4,874 Cr₹5,853 Cr₹7,612 Cr₹9,221 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹848 Cr₹525 Cr₹429 Cr₹95 Cr₹1,027 Cr₹1,498 Cr₹2,069 Cr₹2,166 Cr
Investing₹-612 Cr₹-167 Cr₹-103 Cr₹-5 Cr₹-477 Cr₹-1,033 Cr₹-1,414 Cr₹-2,082 Cr
Financing₹-51 Cr₹-251 Cr₹-186 Cr₹35 Cr₹-363 Cr₹-247 Cr₹-211 Cr₹298 Cr
Free Cash Flow₹848 Cr₹525 Cr₹429 Cr₹95 Cr₹1,027 Cr₹1,498 Cr₹2,069 Cr₹2,166 Cr
Shareholding
Promoter 46.22% Institutions 26.18% Public 27.6%
Efficiency & Working Capital
ROCE15.4%
Interest Coverage41.6
Dividend Payout—
Debtor Days79 d
Inventory Days81 d
Payable Days37 d
Cash Conversion Cycle124 d
Working Capital Days160 d
Shareholding Details

As of 2026-10-31

Promoter46.2%
FII15.4%
DII10.8%
Institutions26.2%
Public27.6%
Promoter Pledge0.9%
No. of Shareholders4,04,384
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026Oct 2026
Promoters49.7%49.7%49.6%49.6%49.6%49.6%49.5%49.5%49.4%49.4%49.4%46.2%
FIIs16.1%17.5%17.5%17.9%17.5%15.5%14.1%15.2%17.4%17%16%15.4%
DIIs9.7%7.9%6.8%5.6%5.6%5.8%5.9%5.4%5.5%5.6%6.2%10.8%
Public24.5%25%26.1%26.9%27.3%29.1%30.6%30%27.8%28%28.4%27.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0.9%
No. of Shareholders2,28,4672,51,4853,02,9443,45,3324,05,2224,29,4344,19,6994,24,1674,10,9704,03,1664,04,1354,04,384
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
V C NannapaneniShareholding of Promoter and Promoter Group14.6%2.86 Cr
Time Cap Pharma Labs Private LimitedShareholding of Promoter and Promoter Group9.2%1.81 Cr
Natsoft Information Systems Pvt LtdShareholding of Promoter and Promoter Group8.2%1.60 Cr
Venkata Satya Swathi KantamaniShareholding of Promoter and Promoter Group8.2%1.60 Cr
Tata Mutual FundPublic Shareholding2.6%50,56,965
Belgrave Investment FundPublic Shareholding2.4%47,45,000
Vistra Itcl India Limited A/c Neelima Nannapaneni TrustShareholding of Promoter and Promoter Group2.1%41,52,535
Life Insurance Corporation Of IndiaPublic Shareholding2%40,09,317
Durga Devi NannapaneniShareholding of Promoter and Promoter Group1.8%34,89,100
Icici PrudentialPublic Shareholding1.6%31,48,725
Nippon Life India Trustee LtdPublic Shareholding1.3%24,71,428
Elm Park Fund LimitedPublic Shareholding1.1%20,57,677
Akash BhanshaliPublic Shareholding1%19,72,291
Rajeev NannapaneniShareholding of Promoter and Promoter Group0.6%11,36,666
Vistra Itcl India Limited A/c Durgadevi Family TrustShareholding of Promoter and Promoter Group0.3%6,00,000
T AnilaShareholding of Promoter and Promoter Group0.3%5,64,920
Neelima Sita NannapaneniShareholding of Promoter and Promoter Group0.2%4,38,347
T Ananda BabuShareholding of Promoter and Promoter Group0.2%4,13,205
Vidyadhari TummalaShareholding of Promoter and Promoter Group0.2%3,67,200
Satya Vani NannapaneniShareholding of Promoter and Promoter Group0.2%3,34,851
Sanjay NannapaneniShareholding of Promoter and Promoter Group0.1%1,56,910
Ndl Infratech Private LimitedShareholding of Promoter and Promoter Group0.1%93,750
Tummala JansiShareholding of Promoter and Promoter Group0%77,100
Kantamani Ratna KumarShareholding of Promoter and Promoter Group0%54,761
Devendranath AlapatiShareholding of Promoter and Promoter Group0%15,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
V C Nannapaneni8,50,0003%2026-10-30
Board of Directors
NameDesignationYear
V C NannapaneniChairman / Executive Director / M D / Promoter2026
Rajeev NannapaneniVice Chairman & CEO2026
PSRK PrasadED / EVP2026
D Linga RaoED & President (Corporate affa2026
A D Murthy ChavaliIndependent Non Exe. Director2026
Vijayabhaskar DronadulaIndependent Non Exe. Director2026
B. LakshminarayanaIndependent Non Exe. Director2026
Kantipudi SumaIndependent Non Exe. Director2026
Nitin JainIndependent Non Exe. Director2026
Venkat RameshCompany Sec. & Compli. Officer2026
Segments — Geography
RegionRevenueShare
India₹653 Cr18.3%
USA₹2,181 Cr61.3%
Rest of the world₹723 Cr20.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2453636
Corporate Actions
TypeDateValueRemark
forthcoming2026-10-01Rights—
forthcoming2026-08-20Dividend—
dividend2026-08-20₹1.5 (75%)Interim
forthcoming2026-08-14Board Meetings—
dividend2026-02-18₹1.5 (75%)Interim 3
dividend2025-11-20₹1.5 (75%)Interim 2
dividend2025-08-19₹2 (100%)Interim 1
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20262,2481026252,300
20262,02100002,021
2026000262552
Insider / Designated-Person Trades

29 recent disclosure(s)

SANDEEP KUMARAcquisition · 22
MAHESH KOKKULAAcquisition · 29
MANTRI PRABHAKAR RAOAcquisition · 100
NEERUKONDA SRINIVASAcquisition · 240
G VASANAcquisition · 300
RAO SREENIVASA PARUPALLIAcquisition · 492
Substantial Acquisitions (SAST)

1 disclosure(s)

Market16/09/2025 · 23,000
Company Information
Incorporated1981
ChairmanV C Nannapaneni
AuditorB S R & Co
Investor Email[email protected]
🌐 www.natcopharma.co.in ↗

📍 Natco House, Road No 2 Banjara Hills, Hyderabad, Telangana, 500033

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Nahar Spinning Mills Ltd.Naman Industries Proxima LimitedNippon Life India Asset Management Ltd.Namo eWaste Management LimitedNarmada Agrobase LimitedNatural Capsules LimitedNath Bio-Genes (India) Ltd.National Aluminium Company Ltd.National Stand (India) LimitedInfo Edge (India) Ltd.Nava LimitedNavin Fluorine International Ltd.All “N” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search